CDA regulates the metabolism of epigenetic nucleosides revealing a therapeutic window in cancer, especially in pancreatic cancer, that has CDA overexpression and is resistant to treatment with other cytidine analogs 43, 44. Here, CDA is linked to familial pancreatic carcinoma.